INTRODUCTION
Burn injuries are among one of the major public health concerns across the globe, particularly in developing countries. Burn is an event that imposes irreplaceable physical, mental, economic, and social consequences, and sometimes death. Sepsis is one of the major causes of death in burn patients. It is estimated that annually, nearly 200,000 people die due to burn injuries around the world. 1 Among this, 30-50% of the deaths are attributed to sepsis and its sequels. 2 Diagnosis of sepsis may be delayed due to the time required for microbiological confirmation of infection. Although advanced mass spectrometry tools in microbiology labs can accelerate the identification of infections in blood, they still require at least 12-24 hours of blood culture before the bacteria reach levels that can be detected. 3 In the absence of sepsis, inappropriate empirical use of antibiotics can have long term consequences for patients by interfering with normal microbiological flora, facilitating development of multidrug resistant bacterial strains, and increasing total cost of hospitalization.
Identifying sepsis early is critical, considering that every 6 hours delay in the diagnosis of sepsis reduces survival by 10%. 4 In contrast to the original idea of explicit immunological dysfunction as a sequel to an infectious stimulus, sepsis is now seen as a more complex syndrome that is characterized by 'impaired homeostasis'. Modern concepts combine immunological aspects with neuroendocrine dys-regulation and failure of protective barriers. This newer concept defines sepsis as a syndrome and focus on the fact that non-infectious stimuli also result in the triggering of defence mechanisms and clinical signs, making it impossible to set discrimination between infectious or non-infectious origin. The pathophysiology of sepsis is characterized by impairment of various body systems on cellular, tissue-specific or functional level. Such a complex nature of sepsis complicates the search for new diagnostic targets.
Severe burn injury is accompanied by a systemic inflammatory response, making traditional indicators of sepsis both insensitive and nonspecific. To address this, the American Burn Association (ABA) published diagnostic criteria in 2007 to standardize the definition of sepsis in these patients.
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These criteria include temperature (>39 °C or <36 °C), progressive tachycardia (>110 beats per minute), progressive tachypnea (>25 breaths per minute not ventilated or minute ventilation >12 L/minute ventilated), thrombocytopenia (<100,000/μl; not applied until 3 days after initial resuscitation), hyperglycaemia (untreated plasma glucose >200 mg/dl, >7 units of insulin/hr intravenous drip, or >25% increase in insulin requirements over 24 hours), and feed intolerance >24 hours (abdominal distension, residuals two times the feeding rate, or diarrhoea > 2500 ml/day).
Biomarkers evaluated in predicting sepsis in burns patients include complement activation (C3), procalcitonin (PCT) and interleukin-6 (IL-6) levels. 6 Another marker is the temporal response of plasma opsonic fibronectin, as measured by both immunoassay and bioassay following burn injury. 7 C-reactive protein (CRP), a plasma biomarker is a serum amyloid P component, belonging to the pentraxin family of calciumdependent ligand-binding proteins. CRP is synthesized in the liver, triggered by IL-6 in response to tissue damages and inflammatory or infectious stimuli. While proinflammatory cytokines (IL-1, IL-6 and tumour necrosis factor ) appear within one hour after the start of infection, and procalcitonin after five hours, CRP appears six to eight hours after onset and peak concentrations reach 36 to 50 hours later. 8 The half-life of CRP is 19 hours and it is cleared mainly by the liver. 9 One of the earliest applications of CRP was in identifying neonates with sepsis in whom clinical manifestations are often nonspecific. CRP levels decrease over the first 48 hours when successful antimicrobial therapy is initiated and hence are used to monitor antibiotic treatment. 10 Given the lack of an adequate predictive marker, the question whether CRP can serve as a predictor for severe infection or sepsis in burns patients remains unanswered. Therefore, our objective was to investigate in a case control study whether CRP can be used as a predic¬tor for sepsis in adult patients with burns. The primary objective of the study was to estimate the rise in Creactive protein in burns patients and to establish its predictive value in sepsis. The secondary objective was to determine how much earlier CRP level allowed the prediction of sepsis.
METHODS
This study was carried out at a tertiary level teaching hospital which is one of the biggest health care institutions in the region. Clearance from Institutional Review Committee at Government Medical College Trivandrum, India was obtained before beginning the study. Before data collection, clearance was obtained from the Human Ethics Committee of the institution. All the patients included in the study gave their informed consent.
The study was done as a case control study, at the General Surgery Department of Government Medical College Trivandrum, from November 2008 till December 2009. Human patients who were admitted within 24 hours of injury with a history of thermal burns were selected for the study. For the sake of better uniformity, only those patients with age group between 20 -70 years and had a burns involving 30 -70% of the body surface area were included in the study. Also, pregnant patients were excluded from the study. The sample size was set at 60, with equal number of cases and controls.
The American Burn Association (ABA) diagnostic criteria, 2007 was used to standardize the definition of sepsis in these patients. 5 Cases were defined as those patients who developed features of sepsis during the treatment, as given in the defining criteria. Controls were those who had no documented sepsis. Cases and controls were matched with respect to age group, sex and percentage of burns in order to minimize bias. Since the grouping of cases was triggered by the detection of features of sepsis, the stratification could be carried out only in between the study. Hence the sampling was stopped only when the required number of cases and controls were obtained.
After recording general survey, the percentage of body surface area (BSA) affected by burns was estimated by the Wallace' Rule of Nines. All patients underwent the same nutritional treatment according to a standardized protocol. They were all resuscitated within the first 24 hours with Ringer's lactate solution as per the Parkland's formula. Plasma expanders and blood components were administered as indicated. Local care included daily hydrotherapy and local application of silver sulfadiazine ointment. Pain relief was administered by intravenous opiate analgesics. Surgery was reserved for escharotomy.
Daily estimation of temperature, pulse rate, blood pressure, respiratory rate, input-output chart and abdomen assessment was done. Blood sugar, platelet count, complete blood picture, renal functions and serum electrolytes were estimated daily. From third day onwards, serial wound culture and sensitivity was done for all the patients. In those patients with features of sepsis, a blood culture was also sent. In septic patients, intensive monitoring was instituted and antibiotics were added as per the results of blood and wound cultures.
CRP was estimated on the second post-burn day and third day, thereafter on alternate days till discharge or till death or till the 15 th day, whichever occurred first. Sample was collected from an indwelling central venous catheter. CRP was estimated by an immuno-turbidometry method with a commercial kit 'Turbilife CRP test'. CRP in serum lower than 10 mg/dl is considered normal for burn patients. Rise was defined as increase in previous value from 3.9-9 mg/dl which is maintained for two days or a single day increase of 10 mg/dl or more based on previous data. Increase in the first 48 hours after a burn was excluded, as trauma itself can cause this rise. All statistical analyses were performed using 'Epi Info' (centre for diseases control). All values are expressed as Mean±Standard deviation. Statistical association was assessed by calculating the odds' ratio. The level of statistical significance was set at a p value less than 0.05.
RESULTS
For the purpose of analysis, the patients were stratified into 2 groups: 1) moderate burns, where the BSA involved was less than 50%; and 2) severe burns, where the BSA involved was more than 50%. As per this study, maximum numbers of cases were in the age group 21-30 years, while the least were in the age group 51-60. The mean age was 32±9 in the case of cases and 32±12 in controls. Females outnumbered males by a ratio of 5:1. This may be explained by the fact that both intentional and non-intentional burns are much more prevalent in females than males in India, due to the socio-cultural scenario. The mean weight was 64.5 kg and the mean height was 157.2 cm. The mean BMI in cases was 25.78±3.02 while the mean BMI in controls was 25.78±2.64. The maximum number of patients had involvement of 31-50% of BSA, followed by 51-70%. In the control patients, CRP levels gradually rose from 3 rd day and reached a peak on 7th day and attained a plateau by 9 th day. Whereas in the septic patients, CRP values rose from 3rd day and peaked on the 5 th day itself and attained a plateau on 7 th day (Table 1) . When a detailed split up was done, CRP reached a peek by 7 th day in control patients with moderate burns (involving <50% of BSA) while it reached a peak on the 5th day itself in severely burned patients (involving >50% BSA) (Figure 1, 2) . In the case group also, CRP reached a peek on 7 th day in patients with moderate burns while it peeked by 5 th day in severely burned patients. However the peak values were higher in patients with sepsis than in non-septic patients. TBSA involved by burns.
Defined rise in CRP levels correctly predicted whether a patient would become septic 87% of the times. Also, on an average, sepsis could be detected two days before the onset of clinically detectable sepsis ( 
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patients, CRP level reached peak values on 7th day and had a mean peak value of 9.68. In the case of septic patients, the same values peaked on 5th day itself and had a mean value of 20.62 (Figure 3) . Of the 34 patients who had a rise in CRP, 28 developed sepsis. Only 2 patients had features of sepsis without concomitant rise in CRP (Table 3) . Serum CRP level predicted sepsis with an efficacy of 87%. The sensitivity was found to be 93% while the specificity was 80%. This was found to be statistically significant, with an Odds ratio of 56 (95% Confidence Intervals between 10.3263 to 303.6915). The z statistic was found to be 4.667 and p value much less than 0.001. CRP level was able to predict sepsis about 2 days before the onset of clinical features. Out of the 34 patients with increased CRP levels, the death rate was moderate, at 35%, which might be explained by the fact that they went through rigorous antibiotic therapy. CRP was not found to predict death, the Odds ratio being low at 1.22 and the p value being not significant, at 0.71.
DISCUSSION
The results of the present study coincide with that of other similar studies in establishing the efficacy of CRP in predicting the onset of sepsis in thermal burns. CRP measurement is cheap and rapidly available, but increases of CRP levels are claimed to be unspecific, since they can be observed after surgery or trauma. 11 High CRP levels correlate with disease severity and are discussed to represent the effectiveness of antimicrobial therapy. As per one clinical study, the authors showed that a rise in CRP serum levels significantly predicted the incidence of major infection around 2.3 days before sepsis occurred. Also, the same authors found that a rise in CRP of 1.5 mg/dl indicated sepsis and a rise of 3 mg/dl indicated severe bacterial or fungal infection. 12 In a large cohort study, the authors determined that CRP has significant correlations to burn size and mortality but the changes of CRP values did not reflect and hence do not predict the incidence of major infection or sepsis. 13 Specific work with patients with burn injuries has been done by Daniels et al. and Faymonville et al. who documented a raise in CRP after a burn.
14, 15 Gottschlich and his study group, who examined CRP levels between days 7 and 10 showed that a raise in CRP was associated with infection and death. 16 Pruchniewski and his colleagues measured CRP serum level at a variety of times after burn and found that in general, CRP levels increased in serum 48 hours after a burn and preceded sepsis. 17 Neely AN et al. in a similar study in burned children showed that when sepsis occurred it was preceded by increased CRP and the increment occurred around 2.3 days before clinical sepsis. 18 Yentis SM et al and Ellis S et al showed that measurement of CRP can be used to monitor the antibiotic therapy and that successful antibiotic therapy lowered CRP levels. 19, 20 As a summary, this study has thrown up positive results regarding the utility of CRP in burn patients. The CRP values correctly predict sepsis in majority of the patients. Also, rise in the serum levels of CRP can give sufficiently early warning regarding onset of sepsis and is able to prompt the initiation of appropriate antibiotic treatment. However, the study does have its own drawbacks in that the sample size was not very high and hence may not be representative enough. However, the results obtained, though small, are significant, particularly in view of obtaining such a strong statistical association. 
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